Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma

Lancet. 1972 Dec 16;2(7790):1273-6. doi: 10.1016/s0140-6736(72)92649-9.
No abstract available

MeSH terms

  • Adolescent
  • Adult
  • Anabolic Agents / adverse effects
  • Androgens / adverse effects*
  • Anemia, Aplastic / drug therapy
  • Carcinoma, Hepatocellular / chemically induced*
  • Carcinoma, Hepatocellular / pathology
  • Child, Preschool
  • Fanconi Syndrome / drug therapy
  • Female
  • Humans
  • Liver Function Tests
  • Liver Neoplasms / chemically induced*
  • Liver Neoplasms / pathology
  • Male
  • Methandrostenolone / adverse effects
  • Methandrostenolone / therapeutic use
  • Methyltestosterone / adverse effects
  • Methyltestosterone / therapeutic use
  • Oxymetholone / adverse effects
  • Oxymetholone / therapeutic use
  • Prednisone / therapeutic use
  • Radionuclide Imaging
  • Testosterone / adverse effects
  • Testosterone / therapeutic use

Substances

  • Anabolic Agents
  • Androgens
  • Testosterone
  • Methandrostenolone
  • Oxymetholone
  • Methyltestosterone
  • Prednisone